Recent moves by the Food and Drug Administration have given digital health companies a big boost during the Covid-19 pandemic. The FDA gave Livongo an emergency use authorization to allow its blood glucose monitors to be used in hospitals, and has loosened requirements around the use of digital tools for mental health.


Please enter your comment!
Please enter your name here